Estrogen receptor codon 594 and HER2 codon 655 polymorphisms and breast cancer risk

Experimental and Molecular Pathology

Volumn 76, Issue 3, 2004, Pages 260-263

  Akisik, Elif ^a   Dalay, Nejat ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Breast cancer; Estrogen receptor; HER2; Polymorphism

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; GENOMIC DNA;

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CODON; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; GENE FREQUENCY; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY;

ADULT; BREAST; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASMS, DUCTAL, LOBULAR, AND MEDULLARY; POLYMORPHISM, GENETIC; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; RNA, MESSENGER;

EID: 2342461768     PISSN: 00144800     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexmp.2003.12.005     Document Type: Article

References (23)

1. Ameyaw M.M., Thornton N., McLeod H.L. Re: population-based, case-control study of HER2 genetic polymorphism and breast cancer risk. J. Natl. Cancer Inst. 92:2000;1947-1948
2. Ameyaw M.M., Tayeb M., Thornton N., Folayan G., Tariq M., Adjei D.O., McLeod H.L. Ethnic variations in the HER-2 codon 655 genetic polymorphism previously associated with breast cancer. J. Hum. Genet. 47:2002;172-175
3. Bargmann C.I., Weinberg R.A. Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain. Cell. 45:1986;649-657
4. Baxter S.W., Campbell I.G. Re: population-based, case-control study of HER2 genetic polymorphism and breast cancer risk. J. Natl. Cancer Inst. 93:2001;557-558
5. Curran J.E., Lea R.A., Rutherford S., Weinstein S.R., Griffiths L.R. Association of estrogen receptor and glucocorticoid receptor gene polymorphisms with sporadic breast cancer. Int. J. Cancer. 95:2001;271-275
6. Fujimoto J., Hirose R., Ichigo S., Skaguchi H., Tamaya T. DNA polymorphism in the B-domain of the estrogen receptor-α among Japanese women. Steroids. 63:1998;146-148
7. Kaneko S., Gerasimova T., Butler W.M., Cupples T.E., Guerry P.L., Greene G.R., Young S.R. The use of FISH on breast core needle samples for the presurgical assessment of HER-2 oncogene status. Exp. Mol. Pathol. 73:2002;61-66
8. Kang H.J., Kim S.W., Kim H.J., Ahn S.J., Bae J.Y., Park S.K., Kang D., Hirvonen A., Choe K.J., Noh D.Y. Polymorphisms in the estrogen receptor-alpha gene and breast cancer risk. Cancer Lett. 178:2002;175-180
9. Keshava C., McCanlies E.C., Keshava N., Wolff M.S., Weston A. Distribution of HER2 V655 genotypes in breast cancer cases and controls in the United States. Cancer Lett. 173:2001;37-41
10. Lehrer S.P., Schmutzler R.K., Rabin J.M., Schachter B.S. An estrogen receptor genetic polymorphism and a history of spontaneous abortion-correlation in women with estrogen receptor positive breast cancer but not in women with estrogen receptor negative breast cancer or in women without cancer. Breast Cancer Res. Treat. 26:1993;175-180
11. Massart F., Becherini L., Gennari L., Facchini V., Genazzani A.R., Brandi M.L. Genotype distribution of the estrogen receptor-alpha gene polymorphisms in Italian women with surgical uterine leiomyomas. Fertil. Steril. 75:2001;567-570
12. McKean-Cowdin R., Kolonel L.N., Press M.F., Pike M.C., Henderson B.E. Germ-line HER-2 variant and breast cancer risk by stage of disease. Cancer Res. 61:2001;8393-8394
13. Paik S., Bryant J., Tan-Chiu E., Yothers G., Park C., Wickerham D.L., Wolmark N. HER2 and choice of adjuvant chemotherapy for breast cancer. National Surgical Adjuvant Breast and Bowel Project Protocol B-15. J. Natl. Cancer Inst. 92:2000;1991-1998
14. Pavao M., Traish A.M. Estrogen receptor antibodies: specificity and utility in detection, localization and analysis of estrogen receptor α and β Steroids. 66:2001;1-16
15. Roodi N., Bailey L.R., Kao W.Y., Verrier C.S., Yee C.J., Dupont W.D., Parl F.F. Estrogen receptor gene analysis in estrogen receptor-positive and receptor-negative primary breast cancer. J. Natl. Cancer Inst. 87:1995;446-451
16. Sasaki M., Tanaka Y., Kaneuchi M., Sakuragi N., Dahiya R. Polymorphisms of estrogen receptor α gene in endometrial cancer. Biochem. Biophys. Res. Commun. 297:2002;558-564
17. Segatto O., King C.R., Pierce J.H., DiFiora P.P., Aaronson S.A. Different structural alterations upregulate in vitro tyrosine kinase activity and transforming potency of the erb B2 gene. Mol. Cell. Biol. 8:1988;5570-5574
18. Stark A., Hulka B.S., Joens S., Novotny D., Thor A.D., Wold L.E., Schell M.J., Melton L.J., Liu E.T., Conway K. HER-2/neu amplification in benign breast disease and the risk of subsequent breast cancer. J. Clin. Oncol. 18:2000;267-274
19. Tsugawa K., Yonemura Y., Hirono Y., Fushida S., Kaji M., Miwa K., Miyazaki I., Yamamoto H. Amplification of the c-met, c-erbB-2 and epidermal growth factor receptor gene in human gastric cancers: correlation to clinical features. Oncology. 55:1998;475-481
20. Walker R.A., Gullick W.J., Varley J.M. An evaluation of immunoreactivity for c-erb B2 protein as a marker of poor short-term prognosis in breast cancer. Br. J. Cancer. 60:1989;426-429
21. Wang-Gohrke S., Claude J.C. Re: population-based, case-control study of HER2 genetic polymorphism and breast cancer risk. J. Natl. Cancer Inst. 93:2001;1657-1659
22. Xie D., Shu X.O., Deng Z., Wen W.Q., Creek K.E., Dai Q., Gao Y.T., Jin F., Zheng W. Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk. J. Natl. Cancer Inst. 92:2000;412-417
23. Yazici H., Altun M., Alatli C., Dogan O., Dalay N. C-erb B2 gene amplification in nasopharyngeal carcinoma. Cancer Invest. 18:2000;6-10